Skip to main content
. 2014 Jan;80(2):766–776. doi: 10.1128/AEM.02886-13

FIG 5.

FIG 5

LC-MS analysis of products formed by the coassay of UGTA1 and CYP52 proteins. (A) Products formed by incubation of oleic acid and UGTA1-transformed cells in combination with control cells (Co) or CYP52E3 (E3)-, CYP52M1 (M1)-, and CYP52N1 (N1)-transformed cells using the resting cell system. (B) Products formed by incubation of various fatty acids and UGTA1 in combination with CYP52M1-transformed cells.